Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | IKK16 | 2.0 | uM | 4 | FGF Basic | 78.0 | 59 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 4 | FGF Basic | 86.5 | 58 | ||||
N2645 | IKK16 | 2.0 | uM | 4 | FGF Basic | 73.0 | 87 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 4 | FGF Basic | 77.0 | 63 | ||||
RA2708 | IKK16 | 2.0 | uM | 4 | FGF Basic | 78.5 | 58 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 4 | FGF Basic | 78.0 | 53 | ||||
RA2159 | 4 | FGF Basic | 74.0 | 61 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 4 | FGF Basic | 77.0 | 61 | ||||
N2645 | 4 | FGF Basic | 70.5 | 62 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 4 | FGF Basic | 73.5 | 72 | ||||
RA2708 | 4 | FGF Basic | 81.0 | 47 | |||||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | FGF Basic | 86.5 | 54 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | FGF Basic | 96.0 | 70 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | FGF Basic | 71.5 | 64 | |
N2645 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | FGF Basic | 75.5 | 62 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | FGF Basic | 78.5 | 72 | |
RA2708 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | FGF Basic | 78.0 | 59 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | FGF Basic | 110.0 | 56 | |
RA2159 | Poly(I:C) | 2 | ug/mL | 4 | FGF Basic | 122.0 | 57 | ||||
N2645 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | FGF Basic | 103.0 | 67 | |
N2645 | Poly(I:C) | 2 | ug/mL | 4 | FGF Basic | 159.0 | 63 | ||||
RA2708 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | FGF Basic | 137.5 | 52 | |
RA2708 | Poly(I:C) | 2 | ug/mL | 4 | FGF Basic | 108.0 | 52 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | FGF Basic | 74.0 | 57 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | FGF Basic | 92.0 | 57 |